As a passionate advocate for transformative cancer therapies, I am committed to uncovering novel insights into targetable tumor mechanisms and predictive biomarkers that enhance therapeutic efficacy. By developing and integrating cutting-edge technologies and advanced informatics, I have defined core target signatures and drug mechanisms of action, paving the way for collaboration and synergy between discovery research, clinical trial development and research clinicians.

With extensive experience in team building and leadership, translational oncology research, biomarker discovery, preclinical and clinical lab development, cutting-edge technology implementation, cancer metabolism modulation, immune oncology drug discovery, and small molecule therapies, I am dedicated to pioneering innovative cancer treatments. My goal is to significantly improve patient outcomes by developing state-of-the-art therapies and identifying those patients most likely to benefit.